Matthieu Jamme
Matthieu Jamme is an expert in Critical care at Assistance Publique - Hôpitaux de Paris (France). Matthieu Jamme has authored 129 publications, the most recent in 2025, and is an investigator in 10 clinical trials, 1 of them ongoing. SLR score: 475 (community average: 125). How the SLR is computed.
LeadR Profile
Critical care
Subspecialties: Pulmonology - Public Health - Rheumatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2013 - 2024
Number : 129
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Iloprost for the Treatment of Severe Septic Shock with Persistent Hypoperfusion: A Double-Blind, Randomized Controlled Trial. PMID 40387381 — epoprostenol, microcirculation, iloprost, shock, septic, critical care, sepsis, therapeutics | Am J Respir Crit Care Med | 2025 | 0 |
| Severe bleeding events among critically ill patients with haematological malignancies. PMID 39373939 — hemorrhage, neoplasms, hospital mortality, critical illness | Ann Intensive Care | 2024 | 4 |
| Hematological features and alternate diagnoses in critically ill thrombotic antiphospholipid syndrome patients. PMID 39073513 — thrombotic microangiopathies, rheumatology, mortality, hospital mortality, heparin, antiphospholipid syndrome, critical illness, diagnosis, blood platelets, thrombocytopenia | Clin Rheumatol | 2024 | 3 |
| Impact of intensive prone position therapy on outcomes in intubated patients with ARDS related to COVID-19. PMID 38935175 — mortality, covid-19, therapeutics, intensive care units, prone position | Ann Intensive Care | 2024 | 3 |
| Répercussions rénales au cours du SDRA OpenAlex W4399472599 — respiratory distress syndrome | Médecine Intensive Réanimation | 2024 | 0 |
Clinical Studies 10
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 8
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Evaluation of the Impact of an Alteration of NAD Metabolism on the Renal Prognosis of Patients Admitted to Intensive Care (NI AKI) NCT07203131 — resuscitation, hospitalization, niacinamide, vitamins, nad, kidney, drug-related side effects and adverse reactions, risk factors, research, therapeutics, renal insufficiency, acute kidney injury, prognosis | N/A | Recruiting | 2025 |
LeadR Networks
Main global connection map